Ian J. Constable

2 Verdun Street
Nedlands, WA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2.

Cell-Based Ciliary Neurotrophic Factor Therapy for Macular Telangiectasia Type 2.

Journal: NEJM evidence

Published: July 22, 2025

Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema.

Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema.

Journal: Scientific reports

Published: February 08, 2023

SIBLING CONCORDANCE IN SYMPTOM ONSET AND ATROPHY GROWTH RATES IN STARGARDT DISEASE USING ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE.

SIBLING CONCORDANCE IN SYMPTOM ONSET AND ATROPHY GROWTH RATES IN STARGARDT DISEASE USING ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE.

Journal: Retina (Philadelphia, Pa.)

Published: March 28, 2022

Longitudinal Analysis of Functional and Structural Outcome Measures in PRPH2-Associated Retinal Dystrophy.

Longitudinal Analysis of Functional and Structural Outcome Measures in PRPH2-Associated Retinal Dystrophy.

Journal: Ophthalmology. Retina

Published: March 13, 2022

Genotype-Specific Lesion Growth Rates in Stargardt Disease.

Genotype-Specific Lesion Growth Rates in Stargardt Disease.

Journal: Genes

Published: November 09, 2021

CLASSIFYING ABCA4 MUTATION SEVERITY USING AGE-DEPENDENT ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE-DERIVED TOTAL LESION SIZE.

CLASSIFYING ABCA4 MUTATION SEVERITY USING AGE-DEPENDENT ULTRA-WIDEFIELD FUNDUS AUTOFLUORESCENCE-DERIVED TOTAL LESION SIZE.

Journal: Retina (Philadelphia, Pa.)

Published: June 14, 2021

Atrophy Expansion Rates in Stargardt Disease Using Ultra-Widefield Fundus Autofluorescence.

Atrophy Expansion Rates in Stargardt Disease Using Ultra-Widefield Fundus Autofluorescence.

Journal: Ophthalmology science

Published: January 14, 2021

Progressive sector retinitis pigmentosa due to c.440G>T mutation in SAG in an Australian family.

Progressive sector retinitis pigmentosa due to c.440G>T mutation in SAG in an Australian family.

Journal: Ophthalmic genetics

Published: October 13, 2020

A novel phenotype in a family with autosomal dominant retinal dystrophy due to c.1430A > G in retinoid isomerohydrolase (RPE65) and c.37C > T in bestrophin 1 (BEST1).

A novel phenotype in a family with autosomal dominant retinal dystrophy due to c.1430A > G in retinoid isomerohydrolase (RPE65) and c.37C > T in bestrophin 1 (BEST1).

Journal: Documenta ophthalmologica. Advances in ophthalmology

Published: September 21, 2020

Edge of Scotoma Sensitivity as a Microperimetry Clinical Trial End Point in USH2A Retinopathy.

Edge of Scotoma Sensitivity as a Microperimetry Clinical Trial End Point in USH2A Retinopathy.

Journal: Translational vision science & technology

Published: June 03, 2020

Retinal pigment epithelium and age-related macular degeneration: A review of major disease mechanisms.

Retinal pigment epithelium and age-related macular degeneration: A review of major disease mechanisms.

Journal: Clinical & experimental ophthalmology

Published: February 27, 2020

Phenotype-genotype correlations in a pseudodominant Stargardt disease pedigree due to a novel ABCA4 deletion-insertion variant causing a splicing defect.

Phenotype-genotype correlations in a pseudodominant Stargardt disease pedigree due to a novel ABCA4 deletion-insertion variant causing a splicing defect.

Journal: Molecular genetics & genomic medicine

Published: October 31, 2019

Showing 1-12 of 27

Last Updated: 09/26/2026